Arrowstreet Capital
RVLP

Arrowstreet Capital’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

Arrowstreet Capital’s Portfolio RVLP Stock Details RVLP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-37,712
Closed -$123K – 2324
2021
Q1 		$123K Sell
37,712
-178,552
-83% -$734K ﹤0.01% 2176
2020
Q4 		$891K Sell
216,264
-115,830
-35% -$668K ﹤0.01% 1860
2020
Q3 		$1.8M Buy
332,094
+187,112
+129% +$1.08M ﹤0.01% 1605
2020
Q2 		$976K Hold
144,982
– – ﹤0.01% 1780
2020
Q1 		$461K Buy
144,982
+85,682
+144% +$456K ﹤0.01% 1547
2019
Q4 		$415K Buy
+59,300
New +$316K ﹤0.01% 1525

Other funds holding RVLP

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
RA
Rovida Advisors Fort Lauderdale, Florida $116M AUM 12.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Arrowstreet Capital's RVLP Position: Q2 2021 in Review

Arrowstreet Capital sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q2 2021, closing a stake of 37,712 shares — an estimated $123K sold.

Arrowstreet Capital first reported a position in RVLP in Q4 2019 and held it in 6 quarters. The position peaked at $1.8M in Q3 2020. 46 funds tracked by Wall St. Rank hold RVLP as of Q2 2021.

  • Arrowstreet Capital reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q2 2021 after selling out during the quarter.
  • Arrowstreet Capital sold 37,712 RVL Pharmaceuticals plc Ordinary Shares shares in Q2 2021, an estimated $123K.
  • Arrowstreet Capital first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q4 2019 and held it in 6 quarters.
  • Arrowstreet Capital's RVL Pharmaceuticals plc Ordinary Shares position peaked at $1.8M in Q3 2020.
  • 46 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q2 2021.

Based on Arrowstreet Capital's 13F filing for Q2 2021, filed 13 Aug 2021.